Loss of TRPV4 decreases NFκB-mediated myometrial inflammation and prevents preterm labor
- PMID: 39989412
- DOI: 10.1096/fj.202402949R
Loss of TRPV4 decreases NFκB-mediated myometrial inflammation and prevents preterm labor
Abstract
Inflammation is a key initiating event in both spontaneous term and preterm labor. However, the link between inflammation and the onset of labor remains incompletely understood. We identified the transient receptor potential vanilloid 4 (TRPV4) channel as a critical regulator of myometrial calcium (Ca2+) entry and contractility. In this study, we aimed to determine if the TRPV4 channel regulates uterine inflammation and its subsequent effects on myometrial contractility in experimental preterm labor. We demonstrated that global loss of TRPV4 protected mice against inflammation-induced preterm labor, decreased baseline myometrial contractility, and diminished lipopolysaccharide-stimulated increases in oxytocin-mediated contraction. Pharmacological inhibition of TRPV4 in human myometrial smooth muscle cells (SMC) blunted lipopolysaccharide (LPS)-induced activation of nuclear factor kappa-B (NFκB) and pro-inflammatory cytokine expression. In contrast, pharmacologic activation of TRPV4 augmented LPS-induced NFκB activation. Further, TRPV4-mediated NFκB activation was dependent on extracellular Ca2+ entry in myometrial SMC. Together, these data show that extracellular Ca2+ entry via TRPV4 potentiates NFκB-mediated inflammation and increases susceptibility to preterm labor. The ability of TRPV4 to modulate both myometrial inflammation and contractility, processes central to the onset of preterm and term labor, suggests that the TRPV4 channel may represent a novel therapeutic target for the treatment of premature birth.
Keywords: contractility; parturition; preterm birth.
© 2025 Federation of American Societies for Experimental Biology.
References
REFERENCES
-
- Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of under‐5 mortality in 2000–15: an updated systematic analysis with implications for the sustainable development goals. Lancet. 2016;388(10063):3027‐3035. doi:10.1016/S0140-6736(16)31593-8
-
- Perin J, Mulick A, Yeung D, et al. Global, regional, and national causes of under‐5 mortality in 2000–19: an updated systematic analysis with implications for the sustainable development goals. Lancet Child Adolesc Health. 2022;6(2):106‐115. doi:10.1016/S2352-4642(21)00311-4
-
- Siricilla S, Knapp KM, Rogers JH, et al. Comparative analysis of myometrial and vascular smooth muscle cells to determine optimal cells for use in drug discovery. Pharmacol Res. 2019;146:104268. doi:10.1016/j.phrs.2019.104268
-
- Lyell DJ, Pullen KM, Mannan J, et al. Maintenance nifedipine tocolysis compared with placebo: a randomized controlled trial. Obstet Gynecol. 2008;112(6):1221‐1226. doi:10.1097/AOG.0b013e31818d8386
-
- Lyell DJ, Pullen K, Campbell L, et al. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial. Obstet Gynecol. 2007;110(1):61‐67. doi:10.1097/01.AOG.0000269048.06634.35
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous
